Pharmaceutical Professional | Pharmacovigilance | CINFA International


Pharmaceutical Professional

Laboratorios Cinfa has a pharmacovigilance system in place to record and evaluate suspected adverse reactions to the drugs that it markets.

The reporting of these suspected adverse reactions by health professionals is one of the main ways of ensuring that this system remains active and useful. If you would like to report a suspected adverse reaction to any of our products, please complete and send the form below.

* Mandatory fields

Patient identification

Notifying person

Suspicious drugs

Other drugs

Adverse Reaction

(*) Seriousness

D: Death | T: Threatens life | H: Hospitalization or extends the length of hospitalization | D: Disability | CR: Clinically relevant | O: Overdose | C: Cancer

(**) Outcome

1: Recovered | 2: Not recovered | 3: Recovering | 4: Recovering with consequences | 5: Fatal

(***) Causality (relationship)

1: Definitely Yes | 2: Probably Yes | 3: Possibly Yes | 4: Possibly No | 5: 5: Probably No | 6: Definitely No | 7: To be determined


Please send this form even though you may not have all the information.

In accordance to the Data Protection Act 15/1999 established on December 13, LABORATORIOS CINFA, S.A. is committed to ensuring complian- ce with the protection, confidentiality and privacy of personal data and security procedures related to the storage of information regarding the notified adverse reaction, and will take any necessary action to prevent its alteration, loss, unauthorized handling or access. Provided information will be added to the “Pharmacovigilance” file with the only purpose of pharmacovigilance control of the CINFA products. Users shall at all times be able to exercise their rights of access, rectification, cancellation and opposition, according to the terms described at Ley Orgánica 15/1999, with regard to personal data provided communicating by means of written document addressed to our registered offices at Polígono Areta, CP 31620 Huarte-Pamplona, Navarra, Spain, or to our e-mail address, to the attention of the Safety Manager.

Please wait...